AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metclass G 1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Impact Healthcare Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Metclass G 1 Tablet SR

DiaGlyco-1 SR, a dual-action antidiabetic medication, is indicated for adult patients with type 2 diabetes. This formulation aids in blood glucose regulation. Administer DiaGlyco-1 SR orally with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. DiaGlyco-1 SR is only one component of a comprehensive diabetes management plan, encompassing dietary modifications, physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect. Learn to recognize its symptoms—sweating, dizziness, headache, trembling—and implement appropriate countermeasures. Maintain regular mealtimes and carry a readily available glucose source. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. DiaGlyco-1 SR is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of cardiovascular disease to your doctor prior to commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is essential, along with potential blood tests to assess hematological parameters and liver function.

Primary Ingredients of Metclass G 1 Tablet SR

There is no text provided to rephrase.

Uses of Metclass G 1 Tablet SR

Managing type 2 diabetes

Major Benefits of Metclass G 1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Metclass G 1 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Metclass G 1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metclass G 1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Metclass G 1 Tablet SR with a meal.

How Metclass G 1 Tablet SR works:

Metformin and Glimepiride, the components of Metclass G 1 SR Tablet, act synergistically to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, achieves glycemic control by reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Metclass G 1 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metclass G 1 Tablet SR during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing it. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Metclass G 1 mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Metclass G 1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Renal function should be regularly monitored during treatment; consult a physician for guidance.

LiverLiverCAUTION

Patients with liver impairment should use Metclass G 1 Tablet SR cautiously, potentially requiring dose modification. A physician's consultation is advised. In those with mild to moderate liver disease, Metclass G 1 Tablet SR is typically initiated at a low dosage; however, it's contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Metclass G 1 Tablet SR :

Should you forget a dose of Metclass G 1 Tablet SR, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metclass G 1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Metclass G 1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Metclass G 1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Metclass G 1 Tablet SR and seek immediate medical attention.
Metclass G 1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for treating type 1 DM.
Metclass G 1 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Metclass G 1 Tablet SR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Metclass G 1 Tablet SR can indeed lower blood sugar (cause hypoglycemia), leading to symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metclass G 1 Tablet SR and alcohol is unsafe. This combination can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Metclass G 1 Tablet SR
42
MRP 51
17% off